Activase is a drug that is utilized for the treatment of acute ischemic stroke (AIS). It functions by dissolving the blood clots that have developed in the brain, permitting a return to normal blood flow. This article will delve into the method of administering Activase for AIS.
Introduction
Activase is a tissue plasminogen activator (tPA) that is used to treat AIS within the first few hours after symptoms begin. It is administered intravenously, which means it is given directly into a vein through an IV line.
Administration Process
The administration process for Activase involves several steps. First, the patient’s medical history and current condition are assessed to determine if they are eligible for treatment with Activase. This includes checking for any allergies or other medical conditions that could interact with the medication.
Next, an IV line is inserted into a vein in the patient’s arm or hand. The Activase medication is then administered through this line over a period of several hours. During this time, the patient will be closely monitored for any signs of bleeding or other complications.
Conclusion
In conclusion, Activase is an important medication used to treat AIS within the first few hours after symptoms begin. It is administered intravenously and requires careful monitoring for any potential complications. If you or someone you know has experienced a stroke, it is important to seek medical attention immediately to determine if Activase or other treatments are appropriate.
